explore -WSS

explore

author：comprehensive 2025-09-28 02:31:03 - browse：9

The cyberattack on Change Healthcare has fractured the country’s health care payment infrastructure. But it also exposed how complicated and vital these electronic pipes are.

Using terms like “clearinghouse” and “electronic data interchange” are quick ways to lose an audience. But Ben Handel, a health economist at the University of California, Berkeley, for the past 13 years, has become intimately familiar with that language. When the Department of Justice sued to block UnitedHealth’s acquisition of Change Healthcare in 2022 — a case the agency ultimately lost — Handel was the government’s witness to explain what could happen to the payments and clearinghouse markets if the deal went through.

He didn’t get into health economics to study the payment plumbing system, but understanding basic concepts about companies like Change Healthcare can illuminate the gravity of what is going on now. For example, the cyberattack and resulting outage isn’t just leading to a cash crunch for providers. It’s also creating uncertainty about how to handle basic requests to approve drugs and care and verify patients’ insurance.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Surgery pushed Ben Carson to fame

knowledge

leisure time

WSS

Problems with a popular proposal to regulate AI in health care

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Chemotherapy before breast cancer surgery might fuel metastasis

Brain technologies pose threats that are all too real, experts warn

Welsh Carson private equity firm escapes from FTC antitrust case

Johnson & Johnson sued for allegedly overpaying for workers' drugs

explore

explore

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

AstraZeneca stays mum on Medicare drug pricing negotiations

Apple is now the first public company to be valued at $3 trillion

AltruBio raises $225 million to develop ulcerative colitis drug

Bright Health sells Medicare Advantage business to Molina

HHS's proposed rule does nothing to address the climate crisis

Walensky prepares to leave CDC — and Congress — behind

A single Democrat is willing to weaken Medicare negotiation power

As demand for Covid shots wanes, Moderna seeks its next success

Primary care doctor shortage won't be solved by free med school tuition

hotspot

Warren pushes Witty on UnitedHealth's control over physicians

340B reform proposal comes out of Senate working group

Primary care doctor shortage won't be solved by free med school tuition

AI gets buy

Unique patient identifier: Experts argue the benefits, pitfalls

The creative science of coining drug names

leisure time

knowledge

leisure time

focus